Total-body [15O]water PET quantifies cerebral blood flow in neurologically healthy adults aged 21 to 86 years.
This observational study assessed quantitative cerebral blood flow (CBF) using total-body [15O]water PET in a cohort of 302 neurologically healthy adults ranging from 21 to 86 years of age. The primary outcome measured was mean grey matter CBF, while secondary outcomes included inter-individual variability, within-subject variability, and reproducibility. No adverse events, serious adverse events, discontinuations, or tolerability issues were reported during the evaluation.
The analysis revealed a mean grey matter CBF of 46.1 mL/(min*dL). Advancing age was associated with a decline in CBF of approximately 7% per decade. Additionally, higher body mass index correlated with lower CBF, estimated at approximately -6% per 10 kg/m2. Sex differences were observed, with women exhibiting higher CBF than men by approximately 7.5%; this disparity was explained by lower blood hemoglobin concentrations in women.
Within-subject reproducibility was characterized as high, supported by intraclass correlation coefficients ranging from 0.78 to 0.89. A key limitation identified was the restricted clinical interpretation of individual CBF measurements due to the absence of large normative datasets that account for physiological variability across the adult lifespan. The practice relevance of these findings suggests that total-body [15O]water PET may enable automated detection of abnormal brain perfusion in clinical PET imaging settings.